These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23984356)

  • 1. Effect of folic acid and vitamin B12 on pemetrexed antifolate chemotherapy in nutrient lung cancer cells.
    Yang TY; Chang GC; Hsu SL; Huang YR; Chiu LY; Sheu GT
    Biomed Res Int; 2013; 2013():389046. PubMed ID: 23984356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
    [No Abstract]   [Full Text] [Related]  

  • 4. Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
    Scagliotti GV
    Lung Cancer; 2005 Oct; 50 Suppl 1():S18-9. PubMed ID: 16291426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(2):825-33. PubMed ID: 17465208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemetrexed as a single agent in the therapy of advanced lung cancer.
    Postmus PE; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):17-22. PubMed ID: 12023788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
    Manegold C
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of PEMVITASTART-An Open-label Randomized Trial Comparing Simultaneous Versus Standard Initiation of Vitamin B
    Baldi M; Behera D; Kaur J; Kapoor R; Singh N
    Clin Lung Cancer; 2017 Jul; 18(4):432-435. PubMed ID: 28073680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed disodium (Eli Lilly).
    Norman P
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1611-22. PubMed ID: 11763166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
    Molina JR; Adjei AA
    Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future directions in the development of pemetrexed.
    Calvert H; Bunn PA
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):54-61. PubMed ID: 12023794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines.
    Smith PG; Marshman E; Calvert AH; Newell DR; Curtin NJ
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):63-7. PubMed ID: 10598557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro schedule-dependent interactions between the multitargeted antifolate LY231514 and gemcitabine in human colon adenocarcinoma cell lines.
    Tesei A; Ricotti L; De Paola F; Amadori D; Frassineti GL; Zoli W
    Clin Cancer Res; 2002 Jan; 8(1):233-9. PubMed ID: 11801564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimetabolites in the management of non-small cell lung cancer.
    Budde LS; Hanna NH
    Curr Treat Options Oncol; 2005 Jan; 6(1):83-93. PubMed ID: 15610718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed: a multitargeted antifolate agent with promising activity in solid tumors.
    Adjei AA
    Ann Oncol; 2000 Oct; 11(10):1335-41. PubMed ID: 11106124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enter Alimta: a new generation antifolate.
    Zhao R; Goldman ID
    Oncologist; 2004; 9(3):242-4. PubMed ID: 15169978
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of thymidylate synthase for resistance to pemetrexed in lung cancer.
    Ozasa H; Oguri T; Uemura T; Miyazaki M; Maeno K; Sato S; Ueda R
    Cancer Sci; 2010 Jan; 101(1):161-6. PubMed ID: 19811498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
    Teicher BA; Chen V; Shih C; Menon K; Forler PA; Phares VG; Amsrud T
    Clin Cancer Res; 2000 Mar; 6(3):1016-23. PubMed ID: 10741729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
    Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.